Bristol-Myers Squibb | Business Finance | Business Contracts

Thirteenth Supplemental Indenture, dated as of March 2, 2022, by and between Bristol-Myers Squibb Company and The Bank of New York Mellon, as Trustee, to the Indenture dated as of... (Filed With SEC on March 2, 2022)

Underwriting Agreement, dated February 15, 2022, among Bristol-Myers Squibb Company and the underwriters named therein (Filed With SEC on February 22, 2022)

Extension Notice, dated June 1, 2021, for the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of September 29, 2011 (Filed With SEC on July 28, 2021)

Amendment and Waiver, dated as of June 22, 2021, to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of September 29, 2011 among Bristol-Myers... (Filed With SEC on July 28, 2021)

Extension Notice, dated June 1, 2021, for the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of July 30, 2012 (Filed With SEC on July 28, 2021)

Amendment, dated as of June 22, 2021, to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of July 30, 2012 among Bristol-Myers Squibb Company,... (Filed With SEC on July 28, 2021)

Extension Notice, dated January 4, 2021, for the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of September 29, 2011 (Filed With SEC on February 10, 2021)

Extension Notice, dated January 4, 2021, for the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of July 30, 2012 (Filed With SEC on February 10, 2021)

Amendment, dated as of January 22, 2021, to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of September 29, 2011 among Bristol-Myers Squibb... (Filed With SEC on February 10, 2021)

Amendment, dated as of January 22, 2021, to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of July 30, 2012 among Bristol-Myers Squibb Company,... (Filed With SEC on February 10, 2021)

Underwriting Agreement, dated November 9, 2020, among Bristol-Myers Squibb Company and the underwriters named therein (Filed With SEC on November 13, 2020)

Twelfth Supplemental Indenture, dated as of November 13, 2020, by and between Bristol-Myers Squibb Company and The Bank of New York Mellon, as Trustee, to the Indenture dated as... (Filed With SEC on November 13, 2020)

Term Loan Agreement, dated as of November 4, 2020, by and among Bristol-Myers Squibb Company, the lenders party thereto and Citibank, N.A., administrative agent (Filed With SEC on November 6, 2020)

Amendment and Waiver, dated as of June 17, 2020, to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of September 29, 2011 among Bristol-Myers... (Filed With SEC on August 6, 2020)

Amendment and Waiver, dated as of June 17, 2020, to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of July 30, 2012 among Bristol-Myers Squibb... (Filed With SEC on August 6, 2020)

Contingent Value Rights Agreement, dated as of November 20, 2019, by and between Bristol-Myers Squibb Company and Equiniti Trust Company, as trustee, including the Form of CVR... (Filed With SEC on February 24, 2020)

Contingent Value Rights Agreement, dated as of November 20, 2019, by and between Bristol-Myers Squibb Company and Equiniti Trust Company, as trustee, including the Form of CVR... (Filed With SEC on November 20, 2019)

Assignment, Assumption and Amendment Agreement, dated as of November 20, 2019, among Bristol-Myers Squibb Company, Celgene Corporation, American Stock Transfer & Trust Company,... (Filed With SEC on November 20, 2019)

Extension Notice, dated May 31, 2019, for the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of September 29, 2011 (Filed With SEC on July 25, 2019)

Amendment and Waiver, dated as of June 20, 2019, to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of September 29, 2011 among Bristol-Myers... (Filed With SEC on July 25, 2019)

Extension Notice, dated May 31, 2019, for the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of July 30, 2012 (Filed With SEC on July 25, 2019)

Amendment, dated as of June 20, 2019, to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of July 30, 2012 among Bristol-Myers Squibb Company,... (Filed With SEC on July 25, 2019)

Purchase Agreement, dated May 7, 2019, by and between Bristol-Myers Squibb Company and the initial purchasers named therein (Filed With SEC on May 8, 2019)

364-Day Revolving Credit Facility Agreement, dated as of January 25, 2019, by and among Bristol-Myers Squibb Company, the lenders party thereto and, Citibank, N.A. and JPMorgan... (Filed With SEC on January 30, 2019)

Three-Year Revolving Credit Facility Agreement, dated as of January 25, 2019, by and among Bristol-Myers Squibb Company, the lenders party thereto and Morgan Stanley Senior... (Filed With SEC on January 30, 2019)

Term Loan Agreement, dated as of January 18, 2019, by and among Bristol-Myers Squibb Corporation, the lenders party thereto and Morgan Stanley Senior Funding, Inc., as... (Filed With SEC on January 22, 2019)

Bridge Facility Commitment Letter, dated as of January 2, 2019, among Morgan Stanley Senior Funding, Inc., MUFG Bank, Ltd. and Bristol-Myers Squibb Company (Filed With SEC on January 4, 2019)

Bristol-Myers Squibb (276) | Business Finance (27)